"For some of these
products, they will be extremely cost effective. But others may not be. I
think, in particular, it's easy to see how a $2 million product may not be
providing the amount of clinical benefit you would want."
— Rachel Sachs, an associate professor at the School of Law at
Washington University in St. Louis, talked with AIS's RADAR on Drug Benefits
about her recent JAMA op-ed, which discusses the rising use of drugs costing
more than $1,000 per claim in Medicaid patients.
Subscribers may read the RADAR on Drug Benefits article in which this quote appeared online. Learn more about subscribing to AIS Health's publications.
No comments:
Post a Comment